Manic syndrome associated with efavirenz overdose.
Blanch
J
J
Corbella
B
B
García
F
F
Parellada
E
E
Gatell
J M
JM
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D048588:Benzoxazines; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000188:drug therapy; D003521:Cyclopropanes; D062787:Drug Overdose; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D013577:Syndrome
D000480:Alkynes; D019380:Anti-HIV Agents; D014150:Antipsychotic Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz; D018967:Risperidone